This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot2: STU1 Ballot 2) based on FHIR (HL7® FHIR® Standard) v6.0.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions
<EvidenceVariable xmlns="http://hl7.org/fhir">
<id value="236536"/>
<meta>
<versionId value="65"/>
<lastUpdated value="2025-03-20T18:40:09.616Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: EvidenceVariable 236536</b></p><a name="236536"> </a><a name="hc236536"> </a><a name="236536-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 65; Last updated: 2025-03-20 18:40:09+0000</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-group-assignment.html">GroupAssignment</a></p></div><blockquote><p><b>RelatesTo</b></p><ul><li>type: part-of</li><li>targetReference: MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)</li></ul></blockquote><p><b>url</b>: <a href="https://fevir.net/resources/EvidenceVariable/236536">https://fevir.net/resources/EvidenceVariable/236536</a></p><p><b>identifier</b>: FEvIR Object Identifier/https://fevir.net/FOI/236536, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-group-assignment-85390-85789</p><p><b>name</b>: GroupAssignment_GLP_1_RA_vs_Standard_care</p><p><b>title</b>: GroupAssignment: GLP-1 RA vs. Standard care</p><p><b>status</b>: Active</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>
</div><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div><p><b>author</b>: Computable Publishing®: MAGIC-to-FEvIR Converter: </p><h3>Definitions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-handling-and-category}">Defined in handling and category elements</span></td></tr></table><p><b>handling</b>: dichotomous variable</p><blockquote><p><b>category</b></p><p><b>name</b>: GLP-1 RA</p><p><b>value</b>: <a href="Group-236532.html">Glucagon-Like Peptide-1 (GLP-1) receptor agonists</a></p></blockquote><blockquote><p><b>category</b></p><p><b>name</b>: Standard care</p><p><b>value</b>: <a href="Group-236530.html">Standard care</a></p></blockquote></div>
</text>
<extension url="http://hl7.org/fhir/uv/ebm/StructureDefinition/relates-to">
<extension url="type">
<valueCode value="part-of"/>
</extension>
<extension url="targetReference">
<valueReference>
<type value="Composition"/>
<identifier>
<type>
<text value="FEvIR Linking Identifier"/>
</type>
<system value="https://fevir.net/FLI"/>
<value value="MAGIC-5288-j1Wqrn-conversion-report"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<display
value="MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"/>
</valueReference>
</extension>
</extension>
<url value="https://fevir.net/resources/EvidenceVariable/236536"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="urn:ietf:rfc:3986"/>
<value value="https://fevir.net/FOI/236536"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<identifier>
<type>
<text value="FEvIR Linking Identifier"/>
</type>
<system value="https://fevir.net/FLI"/>
<value value="MAGIC-5288-j1Wqrn-group-assignment-85390-85789"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<name value="GroupAssignment_GLP_1_RA_vs_Standard_care"/>
<title value="GroupAssignment: GLP-1 RA vs. Standard care"/>
<status value="active"/>
<publisher value="Computable Publishing LLC"/>
<contact>
<telecom>
<system value="email"/>
<value value="support@computablepublishing.com"/>
</telecom>
</contact>
<description
value="This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide."/>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<author>
<name value="Computable Publishing®: MAGIC-to-FEvIR Converter"/>
</author>
<definition>
<concept>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-handling-and-category"/>
<display value="Defined in handling and category elements"/>
</coding>
</concept>
</definition>
<handling value="dichotomous"/>
<category>
<name value="GLP-1 RA"/>
<valueReference>🔗
<reference value="Group/236532"/>
<type value="Group"/>
<identifier>
<type>
<text value="FEvIR Linking Identifier"/>
</type>
<system value="https://fevir.net/FLI"/>
<value value="MAGIC-5288-j1Wqrn-intervention-85390-I-85789"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<display value="Glucagon-Like Peptide-1 (GLP-1) receptor agonists"/>
</valueReference>
</category>
<category>
<name value="Standard care"/>
<valueReference>🔗
<reference value="Group/236530"/>
<type value="Group"/>
<identifier>
<type>
<text value="FEvIR Linking Identifier"/>
</type>
<system value="https://fevir.net/FLI"/>
<value value="MAGIC-5288-j1Wqrn-comparator-85390-C-85789"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<display value="Standard care"/>
</valueReference>
</category>
</EvidenceVariable>